Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (191-200 of 945) with videos related to

Pageof 95
Sort By:
The Journal of Antimicrobial Chemotherapy|September 1, 1988
In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogensR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|November 1, 1988
Antimicrobial activity of MDL 19,592: an oral cephalosporinR N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|June 1, 1976
Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolatesR N Jones, P C Fuchs
Journal of Clinical Microbiology|December 17, 1997
Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagentsD J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacinM A Pfaller, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trialD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1992
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzaeM S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease|August 1, 1992
In vitro activity of CP-74667 compared with four other fluoroquinolonesR N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|February 15, 2001
In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methodsD J Biedenbach, R N Jones
Journal of Clinical Microbiology|February 24, 2001
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999)R N Jones, M A Pfaller
Pageof 95

Showing results (191-200 of 945) with videos related to

Sort By:
Pageof 95
The Journal of Antimicrobial Chemotherapy|September 1, 1988
In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogensR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|November 1, 1988
Antimicrobial activity of MDL 19,592: an oral cephalosporinR N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|June 1, 1976
Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolatesR N Jones, P C Fuchs
Journal of Clinical Microbiology|December 17, 1997
Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagentsD J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacinM A Pfaller, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trialD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1992
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzaeM S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease|August 1, 1992
In vitro activity of CP-74667 compared with four other fluoroquinolonesR N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|February 15, 2001
In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methodsD J Biedenbach, R N Jones
Journal of Clinical Microbiology|February 24, 2001
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999)R N Jones, M A Pfaller
Pageof 95